Immunotherapy drug effective for metastatic triple negative breast cancer – Science Daily
Medical Daily |
Immunotherapy drug effective for metastatic triple negative breast cancer
Science Daily The immunotherapy drug pembrolizumab — already FDA-approved for other forms of cancer-has been found to be effective in patients with metastatic triple negative breast cancer, according to an international clinical trial led by NYU Langone's … Treatment For Triple Negative Breast Cancer; Immunotherapy Drug … |
